by Stacey Johnson | Apr 21, 2017
3D printing is a topic we’ve covered before at Signals. It’s still hot and trendy, and still making the cut on top technology lists. Back in 2012, Chris Anderson, the former editor-in-chief of Wired, predicted that 3D printing “will be bigger than the web.”...
by David Kent | Apr 18, 2017
With the Toronto Blue Jays* off to a terrible start, I was almost dissuaded from reading anything about baseball, until I happened upon the following article: “Stem-cell therapy is poised to disrupt the Tommy John epidemic in baseball.” First, I had to do my standard...
by Stacey Johnson | Apr 14, 2017
If you are a knowledge worker, it may seem as though “innovation” is on everyone’s lips these days. First, Canadians saw Industry Canada renamed Innovation, Science and Economic Development when Prime Minister Trudeau unveiled his first cabinet. Then, Budget 2017,...
by Stacey Johnson | Apr 11, 2017
Earlier this year, the University of Toronto’s Institute of Biomaterials and Biomedical Engineering (IBBME) published its Annual Report, chock full of impressive numbers about enrolment, new programs and research published by its esteemed faculty. (If you’re curious,...
by Stacey Johnson | Apr 7, 2017
Remember back in 2013 when Tourism Australia launched the “Best jobs in the world” global youth campaign? Well, the Waag Society in Amsterdam may just have the “coolest science summer job” around! (Yes, Waag Society, you can quote me on this.) The Waag Society, an...
by Hamideh Emrani | Apr 4, 2017
The month of March is a time for celebrating women around the world. As a science enthusiast, I have been so inspired by the women I see succeeding in the research field. Since I started writing for this blog, I have had the chance to write about and interview female...
by Stacey Johnson | Mar 31, 2017
via GIPHY Artificial Intelligence (AI) already permeates our culture and that’s only going to increase with time and advances to the technology. Some think this is good news, progress and inevitable while others, like Stephen Hawking for example, fear where AI could...
by Elizabeth Csaszar | Mar 27, 2017
Research and development (R&D) of a medical therapeutic is a long slog. This isn’t news to anyone working in the field. The average time to bring a new drug product to market is over a decade. Moreover, this is the timeline when everything progresses well –...
by Erin Sugar | Mar 24, 2017
The eighth annual Toronto StemCellTalks (SCT) symposium took place on March 10, 2017, in Toronto’s urban innovation hub (and CCRM’s new home), MaRS Discovery District. SCT is a national stem cell biology outreach program for high school students in partnership with...
by Holly Wobma | Mar 22, 2017
For most areas of medicine, the supply of a treatment can easily meet demand (access issues aside). Need an antibody? A steroid? Millions of pills are manufactured every day. The case could not be more different for solid organ transplantation, for which the list of...
Comments